PTPN22 and rheumatoid arthritis: gratifying replication.
PTPN22 and rheumatoid arthritis: gratifying replication.
复制标题
DOI:
10.1002/art.21125
复制
发表时间:
2005-07
影响因子:
--
通讯作者:
P. Gregersen;F. Batliwalla
中科院分区:
文献类型:
--
作者:
P. Gregersen;F. Batliwalla
Two articles in this issue of Arthritis & Rheumatism (1, 2) provide critical confirmation of the association between rheumatoid arthritis (RA) and a functional polymorphism located in the coding region of PTPN22, the gene that encodes the intracellular protein tyrosine phosphatase nonreceptor 22 (PTPN22; also known as Lyp, a lymphoid-specific phosphatase). This observation now stands as the most robust and reproducible genetic association with RA outside of the HLA region. It is especially satisfying that the PTPN22 620W variant also predisposes to a variety of other autoimmune disorders in addition to RA, lending strong support to the opinion that common mechanisms and common molecular pathways underlie these disorders. What is most important is that this discovery is clearly useful in the sense that it raises a host of intriguing questions. We know just enough about the function of PTPN22 to proceed immediately with a rich variety of new experimental approaches that will encompass biochemistry, cell biology, animal disease models, population genetics, and epidemiology.The year 2004 was clearly a landmark in terms of PTPN22 and human autoimmune disease. In March 2004, using a candidate gene approach, Bottini et al (3) reported that the minor allele (T) at nucleotide 1858 of PTPN22 confers a predisposition to type 1 diabetes in US and Italian populations. This polymorphism results in a substitution of tryptophan (W) for arginine (R) at codon 620 of the PTPN22 protein. Working independently and combining a broad screen of functional single-nucleotide polymorphisms guided by previously